References
- Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 1997; 49(Suppl 5A)14–40
- Sant GR. Interstitial cystitis. Monogr Urol 1991; 12: 37–63
- Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 1988;140:203–6.
- Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodynam 2002; 21: 167–78
- Yamada T, Nishimura M, Mita H. Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients. World J Urol 2007; 25: 407–13
- Wilkinson DR, Erickson DR. Urinary and serologic markers for interstitial cystitis: an update. Curr Urol Rep 2006; 7: 414–22
- Van QN, Klose JR, Lucas DA. The use of urine proteomics and metabonomic patterns for the diagnosis of interstitial cystitis and bacterial cystitis. Dis Markers ,2003 2004; 19: 169–83
- Liu BCS, Ehrlich JR. Proteomics approaches to urologic diseases. Expert Rev Proteomics 2006; 3: 283–96
- Moraes TJ, Chow CW, Downey GP. Proteases and lung injury. Crit Care Med 2003; 31: S189–94
- Zeiher BG, Matsuoka S, Kawabata K, Repine JE. Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Crit Care Med 2002; 30: S281–7
- Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 1978; 12: 381–92
- Elgebaly SA, Allam ME, Walzak P, Jr, Oselinsky D, Gillies C, Yamase H. Urinary neutrophil chemotactic factors in interstitial cystitis patients and a rabbit model of bladder inflammation. J Urol 1992; 147: 1382–7
- O'Leary MP, Sant GR, Fowler FJ, Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997; 49: 58–63
- Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850–8
- Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365–76
- Betsuyaku T. The mechanism of airway obstruction in the development of COPD. Nippon Rinsho 2003; 61: 2133–7
- Nishina K, Mikawa K, Takao Y, Maekawa N, Shiga M, Obara H. ONO-5046, an elastase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Anesth Analg 1997; 84: 1097–103
- Yang JJ, Kettritz R, Falk RJ, Jennette JC, Gaido ML. Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am J Pathol 1996; 149: 1617–26
- Uehara A, Muramoto K, Takada H, Sugawara S. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. J Immunol 2003; 170: 5690–6
- Ludwig M, Vidal A, Diemer T, Pabst W, Failing K, Weidner W. Chronic prostatitis/chronic pelvic pain syndrome: seminal markers of inflammation. World J Urol 2003; 21: 82–5
- Zuraw BL, Sugimoto S, Parsons CL, Hugli T, Lotz M, Koziol J. Activation of urinary kallikrein in patients with interstitial cystitis. J Urol 1994; 152: 874–8
- Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, Demers LM, et al. A comparison of multiple urine markers for interstitial cystitis. J Urol 2002; 167: 2461–9
- Keay S, Szekely Z, Conrads TP, Veenstra TD, Barchi JJ, Jr, Zhang C-O, et al. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci 2004; 101: 11803–8
- Keay S, Zhang CO, Chai T, Warren J, Koch K, Grkovic D, et al. Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 2004; 63: 22–6